PMID: 9535242Apr 16, 1998Paper

Selective use of vancomycin to prevent coagulase-negative staphylococcal nosocomial bacteremia in high risk very low birth weight infants

The Pediatric Infectious Disease Journal
R J BaierE G Brown

Abstract

To determine whether vancomycin added to parental nutrition (PN) fluids could prevent nosocomial infections in very low birth weight newborns and which infants would benefit most from prophylaxis. Double blind, randomized controlled study. Very low birth weight infants receiving PN in a tertiary neonatal intensive care unit. Thirty-eight infants with and without central vascular catheters were randomized to receive no medication or 25 microg/ml vancomycin added to PN for the duration of the infant's PN requirements. The addition of 25 microg/ml vancomycin to PN prevented bacteremia in very low birth weight infants receiving PN. There was a significant reduction in the number of coagulase-negative staphylococcal (CONS) bacteremias (defined as isolation of the same organism from two positive blood cultures) during PN (5 vs. 0; P = 0.037) as well as the total number of bacteremias and fungemias (9 vs. 1; P = 0.036). The total number of hospital days (108 +/- 13 vs. 76 +/- 6; P = 0.039) were reduced in infants receiving vancomycin. Infants with birth weights of < 1000 g who received corticosteroids for treatment of chronic lung disease benefitted most from treatment. No vancomycin-resistant strains of CONS or enterococci were detec...Continue Reading

References

Jun 10, 1976·The New England Journal of Medicine·V G HemmingM R Britt
Jan 1, 1990·The Journal of Infectious Diseases·R S SchwalbeP H Gilligan
Nov 1, 1987·The Pediatric Infectious Disease Journal·B K SchmidtE L Ford-Jones
Apr 1, 1989·Antimicrobial Agents and Chemotherapy·J W FroggattG L Archer
Apr 1, 1987·The Pediatric Infectious Disease Journal·R T HallI Zorbas
May 1, 1983·American Journal of Diseases of Children·S BaumgartR A Polin
Oct 1, 1981·Archives of Disease in Childhood·O BattistiP A Davies
Apr 1, 1995·The Journal of Pediatrics·M A RojasG Silva-Neto
Aug 1, 1994·The Journal of Pediatrics·M A KacicaR A Venezia

❮ Previous
Next ❯

Citations

Jul 14, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nasia Safdar, Dennis G Maki
Sep 18, 2002·The Journal of Perinatal & Neonatal Nursing·Patricia Marie Dawson
Mar 12, 2004·The Pediatric Infectious Disease Journal·Nahed O ElhassanRobert A Sinkin
Nov 26, 2010·The Pediatric Infectious Disease Journal·Walter ZinggDidier Pittet
Jan 26, 2011·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Marieke A C HemelsTannette G Krediet
Feb 24, 2006·Journal of Perinatal Medicine·Agnes van den HoogenAndré Fleer
May 14, 2004·Clinical Pharmacokinetics·Matthijs de HoogJohn N van den Anker
Jun 14, 2013·Clinical & Developmental Immunology·Elizabeth A MarchantPascal M Lavoie
Nov 19, 2004·Journal of Perinatology : Official Journal of the California Perinatal Association·R John BaierKrishna Yanamandra
Jan 31, 2006·American Journal of Infection Control·Silvia F CostaElias J Anaissie
Feb 21, 2007·Journal of Chemotherapy·V FanosM Testa
Feb 14, 2015·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Ru-Jeng TengMark L Hudak
May 4, 2004·The Lancet Infectious Diseases·Silvia F CostaElias J Anaissie
Aug 15, 2001·Journal of Perinatology : Official Journal of the California Perinatal Association·A Craft, N Finer
May 5, 2000·The Cochrane Database of Systematic Reviews·A P CraftK J Barrington
Feb 28, 2015·Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society·Michelle A HoffmanAnn L Anderson-Berry
Feb 7, 2008·The Cochrane Database of Systematic Reviews·L A JardineM W Davies
Jul 15, 2015·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Gail E ReynoldsJonathan M Klein

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.